Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × OTHER × sugemalimab × Clear all

Phase

Phase NA 1 Phase 2/3 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Exercise 356 Blood Specimen Collection 294 Standard of Care 258 Surveys and Questionnaires 215 Magnetic Resonance Spectroscopy 215 Radiosurgery 210 Educational Status 200 Radiotherapy 196 Methods 196 Early Intervention, Educational 175 Practice Guidelines as Topic 130 Interviews as Topic 122 Drug Therapy 110 Biopsy 110 Acupuncture Therapy 109 Control Groups 106 Surgical Procedures, Operative 104 Palliative Care 89 Therapeutics 85 Resistance Training 80 Counseling 79 Magnetic Resonance Imaging 76 Cyclophosphamide 76 Saline Solution 74 Cognitive Behavioral Therapy 67 Radiofrequency Ablation 64 Cisplatin 64 Specimen Handling 63 Radiotherapy, Intensity-Modulated 61 Yoga 58

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07247227 2025-11-25

Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC

Peking Union Medical College

Phase NA Recruiting

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡